Warren H S, McPhun V, Bezos A, Parish C R
Cancer Research Unit, Woden Valley Hospital, Australian Capital Territory.
Immunology. 1988 Feb;63(2):345-7.
In this study, results are presented showing that the T11(3) epitope of the CD2 molecule is expressed on unfractionated peripheral blood mononuclear cells, resting T cells and activated T cells. T11(3) is not therefore, an activation-specific CD2 epitope. Sheep erythrocytes (SRC) which present a cell-surface ligand for CD2 could not effectively replace anti-T11(2) in initiating proliferation of resting T cells, stimulated by anti-T11(3). SRC with either of these anti-CD2 monoclonal antibodies did activate resting T cells, but proliferation required the presence of added IL-2.
在本研究中,结果表明CD2分子的T11(3)表位在未分级的外周血单个核细胞、静息T细胞和活化T细胞上表达。因此,T11(3)不是一个活化特异性的CD2表位。作为CD2细胞表面配体的绵羊红细胞(SRC)不能有效地替代抗T11(2)来启动由抗T11(3)刺激的静息T细胞的增殖。这两种抗CD2单克隆抗体中的任何一种与SRC确实能激活静息T细胞,但增殖需要添加白细胞介素-2。